List of Tables
    Table 1. Key Players of Genome-Based Drug in Global Market
    Table 2. Top Genome-Based Drug Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Genome-Based Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Genome-Based Drug Revenue Share by Companies, 2017-2022
    Table 5. Global Genome-Based Drug Sales by Companies, (Kiloton), 2017-2022
    Table 6. Global Genome-Based Drug Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Genome-Based Drug Price (2017-2022) & (US$/Ton)
    Table 8. Global Manufacturers Genome-Based Drug Product Type
    Table 9. List of Global Tier 1 Genome-Based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Genome-Based Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Genome-Based Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Genome-Based Drug Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Genome-Based Drug Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Genome-Based Drug Sales (Kiloton), 2017-2022
    Table 15. By Type - Global Genome-Based Drug Sales (Kiloton), 2023-2028
    Table 16. By Application – Global Genome-Based Drug Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Genome-Based Drug Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Genome-Based Drug Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Genome-Based Drug Sales (Kiloton), 2017-2022
    Table 20. By Application - Global Genome-Based Drug Sales (Kiloton), 2023-2028
    Table 21. By Region – Global Genome-Based Drug Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Genome-Based Drug Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Genome-Based Drug Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Genome-Based Drug Sales (Kiloton), 2017-2022
    Table 25. By Region - Global Genome-Based Drug Sales (Kiloton), 2023-2028
    Table 26. By Country - North America Genome-Based Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Genome-Based Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Genome-Based Drug Sales, (Kiloton), 2017-2022
    Table 29. By Country - North America Genome-Based Drug Sales, (Kiloton), 2023-2028
    Table 30. By Country - Europe Genome-Based Drug Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Genome-Based Drug Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Genome-Based Drug Sales, (Kiloton), 2017-2022
    Table 33. By Country - Europe Genome-Based Drug Sales, (Kiloton), 2023-2028
    Table 34. By Region - Asia Genome-Based Drug Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Genome-Based Drug Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Genome-Based Drug Sales, (Kiloton), 2017-2022
    Table 37. By Region - Asia Genome-Based Drug Sales, (Kiloton), 2023-2028
    Table 38. By Country - South America Genome-Based Drug Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Genome-Based Drug Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Genome-Based Drug Sales, (Kiloton), 2017-2022
    Table 41. By Country - South America Genome-Based Drug Sales, (Kiloton), 2023-2028
    Table 42. By Country - Middle East & Africa Genome-Based Drug Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Genome-Based Drug Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Genome-Based Drug Sales, (Kiloton), 2017-2022
    Table 45. By Country - Middle East & Africa Genome-Based Drug Sales, (Kiloton), 2023-2028
    Table 46. Sandoz International Corporate Summary
    Table 47. Sandoz International Genome-Based Drug Product Offerings
    Table 48. Sandoz International Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 49. Teva pharmaceutical industries Corporate Summary
    Table 50. Teva pharmaceutical industries Genome-Based Drug Product Offerings
    Table 51. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 52. Mylan Corporate Summary
    Table 53. Mylan Genome-Based Drug Product Offerings
    Table 54. Mylan Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 55. 3SBio Corporate Summary
    Table 56. 3SBio Genome-Based Drug Product Offerings
    Table 57. 3SBio Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 58. Shanghai Fosun Pharmaceutical Corporate Summary
    Table 59. Shanghai Fosun Pharmaceutical Genome-Based Drug Product Offerings
    Table 60. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 61. Tonghua Dongbao Pharmaceutical Corporate Summary
    Table 62. Tonghua Dongbao Pharmaceutical Genome-Based Drug Product Offerings
    Table 63. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 64. Biocon Corporate Summary
    Table 65. Biocon Genome-Based Drug Product Offerings
    Table 66. Biocon Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 67. Reliance Life Sciences Corporate Summary
    Table 68. Reliance Life Sciences Genome-Based Drug Product Offerings
    Table 69. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 70. Probiomed Corporate Summary
    Table 71. Probiomed Genome-Based Drug Product Offerings
    Table 72. Probiomed Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 73. Biosidus Corporate Summary
    Table 74. Biosidus Genome-Based Drug Product Offerings
    Table 75. Biosidus Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 76. AMEGA Biotech Corporate Summary
    Table 77. AMEGA Biotech Genome-Based Drug Product Offerings
    Table 78. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 79. Celltrion Corporate Summary
    Table 80. Celltrion Genome-Based Drug Product Offerings
    Table 81. Celltrion Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 82. LG Life Science Corporate Summary
    Table 83. LG Life Science Genome-Based Drug Product Offerings
    Table 84. LG Life Science Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 85. Dong-A Pharmaceutical Corporate Summary
    Table 86. Dong-A Pharmaceutical Genome-Based Drug Product Offerings
    Table 87. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 88. Genome-Based Drug Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
    Table 89. Global Genome-Based Drug Capacity Market Share of Key Manufacturers, 2020-2022
    Table 90. Global Genome-Based Drug Production by Region, 2017-2022 (Kiloton)
    Table 91. Global Genome-Based Drug Production by Region, 2023-2028 (Kiloton)
    Table 92. Genome-Based Drug Market Opportunities & Trends in Global Market
    Table 93. Genome-Based Drug Market Drivers in Global Market
    Table 94. Genome-Based Drug Market Restraints in Global Market
    Table 95. Genome-Based Drug Raw Materials
    Table 96. Genome-Based Drug Raw Materials Suppliers in Global Market
    Table 97. Typical Genome-Based Drug Downstream
    Table 98. Genome-Based Drug Downstream Clients in Global Market
    Table 99. Genome-Based Drug Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Genome-Based Drug Segment by Type
    Figure 2. Genome-Based Drug Segment by Application
    Figure 3. Global Genome-Based Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Genome-Based Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Genome-Based Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. Genome-Based Drug Sales in Global Market: 2017-2028 (Kiloton)
    Figure 8. The Top 3 and 5 Players Market Share by Genome-Based Drug Revenue in 2021
    Figure 9. By Type - Global Genome-Based Drug Sales Market Share, 2017-2028
    Figure 10. By Type - Global Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Genome-Based Drug Price (US$/Ton), 2017-2028
    Figure 12. By Application - Global Genome-Based Drug Sales Market Share, 2017-2028
    Figure 13. By Application - Global Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Genome-Based Drug Price (US$/Ton), 2017-2028
    Figure 15. By Region - Global Genome-Based Drug Sales Market Share, 2017-2028
    Figure 16. By Region - Global Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Genome-Based Drug Sales Market Share, 2017-2028
    Figure 19. US Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Genome-Based Drug Sales Market Share, 2017-2028
    Figure 24. Germany Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. France Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Genome-Based Drug Sales Market Share, 2017-2028
    Figure 33. China Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. India Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Genome-Based Drug Sales Market Share, 2017-2028
    Figure 40. Brazil Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Genome-Based Drug Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Genome-Based Drug Sales Market Share, 2017-2028
    Figure 44. Turkey Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Genome-Based Drug Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Genome-Based Drug Production Capacity (Kiloton), 2017-2028
    Figure 49. The Percentage of Production Genome-Based Drug by Region, 2021 VS 2028
    Figure 50. Genome-Based Drug Industry Value Chain
    Figure 51. Marketing Channels